Invention Grant
- Patent Title: Cancer stem cell targeted cancer vaccines
-
Application No.: US16599031Application Date: 2019-10-10
-
Publication No.: US11672847B2Publication Date: 2023-06-13
- Inventor: Ivan Bergstein , Christopher Brooks , Thomas P. Cirrito
- Applicant: Stemline Therapeutics, Inc.
- Applicant Address: US NY New York
- Assignee: Stemline Therapeutics, Inc.
- Current Assignee: Stemline Therapeutics, Inc.
- Current Assignee Address: US NY New York
- Agency: McNeill Baur PLLC
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K38/17 ; A61K38/20 ; A61K38/30 ; A61K38/21 ; A61K31/437 ; A61K38/16 ; A61K38/19 ; A61K38/45 ; C07K14/33 ; C07K14/47 ; C07K14/54 ; C12N9/12

Abstract:
Provided herein are cancer stem cell targeted cancer vaccines and methods for treating and vaccinating against cancer. Also contained herein are regimens by which cancer stem cell targeted cancer vaccines are administered, such regimens comprising peptides, compositions, immunomodulatory agents, and emulsifiers. Also provided are the patient populations to which the regimens are to be administered, and the dosages, schedules, route of administration for the regimens.
Public/Granted literature
- US20210093701A1 Cancer Stem Cell Targeted Cancer Vaccines Public/Granted day:2021-04-01
Information query